Title
Category
Credits
Event date
Cost
  • Wilson Disease
  • Genetics
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Due to Wilson disease myriad manifestations, its rarity, and its range of symptoms, differential diagnosis may be challenging, leading to delays in treatment. This Neuroscience Commentary reviews diagnostic acumen and the latest updates in the field.
  • Bipolar Disorder
  • Depression
  • Antipsychotics
  • Diagnostic Tools
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Experts offer a review of the fundamentals of diagnosing and treating tardive dyskinesia.
  • Bipolar Disorder
  • Depression
  • Diagnostic Tools
  • Psychopharmacology
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Join Dr Goldberg as he reviews factors that impact the diagnosis of bipolar disorder and current treatments for bipolar depression in adults.
  • Bipolar Disorder
  • Depression
  • Child and Adolescent Psychiatry
  • Diagnostic Tools
  • Psychopharmacology
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are the evidence-based pharmacologic treatment approaches for pediatric patients with bipolar depression?
  • Bipolar Disorder
  • Depression
  • Antidepressants
  • Antipsychotics
  • Child and Adolescent Psychiatry
  • Diagnostic Tools
  • Mood Disorders
  • Patient/Physician Communication
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • Education
  • Functional Impairment
  • Geriatric Psychiatry
  • Neuroimaging
  • Neurology
  • Patient/Physician Communication
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Drs Anderson and Malone cover the types of dementia and their indicators, ways to approach care for mild cognitive impairment (MCI) and mild dementia, and treatment options available or in the pipeline for disease intervention. Early diagnosis and intervention of MCI and mild dementia can slow disease progression and optimize outcomes for both patients and caregivers.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • Education
  • Functional Impairment
  • Geriatric Psychiatry
  • Neuroimaging
  • Neurology
  • Patient/Physician Communication
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Drs Anderson and Malone discuss the burden of, signs and symptoms of, diagnostic tools and criteria for mild cognitive impairment (MCI) and mild/early dementia and the benefits of early diagnosis. Early diagnosis and intervention of MCI and mild dementia can slow disease progression and optimize outcomes for both patients and caregivers.
  • Sleep
  • Comorbidity
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Insomnia is often comorbid with psychiatric, medical, and neurologic disorders. Follow along as Dr Rosenberg discusses the bidirectional relationship between insomnia disorder and frequently co-occurring conditions.
  • Movement Disorders
  • Psychotic Disorders
  • Side Effects
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Clinicians should screen regularly for signs and symptoms of tardive dyskinesia and educate patients and caregivers on what to look for and report, leading to earlier intervention and better quality of life.

Pages